Cargando…
Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects?
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946074/ https://www.ncbi.nlm.nih.gov/pubmed/36892332 http://dx.doi.org/10.5826/dpc.1301a42 |
_version_ | 1784892256670449664 |
---|---|
author | Conforti, Claudio Dell’Aquila, Carmen Tognetto, Daniele Zalaudek, Iris Di Meo, Nicola |
author_facet | Conforti, Claudio Dell’Aquila, Carmen Tognetto, Daniele Zalaudek, Iris Di Meo, Nicola |
author_sort | Conforti, Claudio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9946074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Mattioli 1885 |
record_format | MEDLINE/PubMed |
spelling | pubmed-99460742023-02-23 Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? Conforti, Claudio Dell’Aquila, Carmen Tognetto, Daniele Zalaudek, Iris Di Meo, Nicola Dermatol Pract Concept Letter to Editor Mattioli 1885 2023-01-01 /pmc/articles/PMC9946074/ /pubmed/36892332 http://dx.doi.org/10.5826/dpc.1301a42 Text en ©2023 Conforti et al. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. |
spellingShingle | Letter to Editor Conforti, Claudio Dell’Aquila, Carmen Tognetto, Daniele Zalaudek, Iris Di Meo, Nicola Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? |
title | Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? |
title_full | Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? |
title_fullStr | Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? |
title_full_unstemmed | Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? |
title_short | Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects? |
title_sort | eyelid lentigo maligna treated with imiquimod 5%: should we fear of ocular side effects? |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946074/ https://www.ncbi.nlm.nih.gov/pubmed/36892332 http://dx.doi.org/10.5826/dpc.1301a42 |
work_keys_str_mv | AT conforticlaudio eyelidlentigomalignatreatedwithimiquimod5shouldwefearofocularsideeffects AT dellaquilacarmen eyelidlentigomalignatreatedwithimiquimod5shouldwefearofocularsideeffects AT tognettodaniele eyelidlentigomalignatreatedwithimiquimod5shouldwefearofocularsideeffects AT zalaudekiris eyelidlentigomalignatreatedwithimiquimod5shouldwefearofocularsideeffects AT dimeonicola eyelidlentigomalignatreatedwithimiquimod5shouldwefearofocularsideeffects |